Dopamine natriuresis in salt-repleted, water-loaded humans: A dose- response study

British Journal of Clinical Pharmacology

Volumn 43, Issue 5, 1997, Pages 509-520

  Olsen, Niels Vidiendal ^a,d   Olsen, Michael Hecht ^a   Bonde, Jan ^a   Kanstrup, Inge Lis ^a   Plum, Inger ^b   Strandgaard, Svend ^a   Leyssac, Paul P ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

dopamine; dose response; kidney function; lithium clearance; natriuresis; renal haemodynamics; sodium; tubular function

Indexed keywords

DOPAMINE; LITHIUM; SODIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY PLASMA FLOW; KIDNEY PROXIMAL TUBULE; MALE; NATRIURESIS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM ABSORPTION; SODIUM RESTRICTION; WATER LOADING;

EID: 0030919498     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00589_43_5.x     Document Type: Article

References (50)

1. McNay JL, McDonald RH, Goldberg LI. Direct renal vasodilation produced by doparmine in the dog. Circ Res 1965; 16: 510-517.
2. Chapman BJ, Horn NM, Munday KA, Robertson MJ. The actions of dopamine and of sulpiride on regional blood flows in the rat kidney. J Physiol 1980; 298: 437-452.
3. Edwards RM. Comparison of the effects of fenoldopam, SK&F R-87516 and dopamine on renal arterioles in vitro. Eur J Pharmacol 1986; 126: 167-170.
4. Steinhausen M, Weis S, Fleming J, Dussel R, Parekh N. Responses of in vivo renal microvessels to dopamine. Kidney Int 1986; 30: 361-370.
5. Felder RA, Felder CC, Eisner GM, Jose PA. The dopamine receptor in adult and maturing kidney. Am J Physiol 1989; 257: F315-F327.
6. Goldberg LI. The role of dopamine receptors in the treatment of congestive heart failure. J Cardiovasc Pharmacol 1989; 14 (Suppl. 5): S19-S27.
7. Lokhandwala MF, Amenta F. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J 1991; 5: 3023-3030.
8. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 1990; 259: F297-F303.
9. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 1987; 252: F39-F45.
10. +-ATPase in renal tubule cells. Proc Natl Acad Sci 1989; 86: 8068-8072.
11. Slobodyansky E, Aoki Y, Gaznabi AKM, Aviles DH, Fildes RD, Jose PA. Dopamine and protein phophatase activity in renal proximal tubules. Am J Physiol 1995; 268: F279-F284.
12. 1 receptors in the human kidney. J Pharmacol Exp Ther 1993; 264: 431-437.
13. Bello-Reus E, Higashi Y, Kaneda Y. Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule. Am J Physiol 1982; 242: F634-F640.
14. Davis BB, Walter MJ, Murdaugh HV. The mechanism of the increase in sodium excretion following dopamine infusion. Proc Soc Exp Biol Med 1968; 129: 210-213.
15. 1-induced renal vasodilation. Am J Physiol 1990; 258: F627-F635.
16. Olsen NV, Hansen JM, Ladefoged SD, Fogh-Andersen N, Leyssac PP. Renal tubular reabsorption of sodium and water during infusion of low-dose dopamine in normal man. Clin Sci 1990; 78: 503-507.
17. Olsen NV, Lund J, Jensen PF, et al. Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993; 79: 685-694.
18. DiBona GF. Update on renal neurology: role of the renal nerves in formation of edema. Mayo Clin Proc 1989; 64: 469-472.
19. D'orio V, Allaf DE, Juchmés J, Marcelle R. The use of low doses of dopamine in intensive care medicine. Arch Int Physiol Biochim 1984; 92: S11-S20.
20. Smit AJ, Meijer S, Wesseling H, Reitsma WD, Donker AJM. Impaired renal hemodynamic but conserved natriuretic response to dopamine in patients with renal disease, Nephron 1989; 52: 338-346.
21. Beregovich J, Bianchi C, Rubler S, Lomnitz E, Cagin N, Levitt B. Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am Heart J 1974; 87: 550-557.
22. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA. Evaluation of the lithium clearance method: direct analysis of tubular handling by micropuncture. Kidney Int 1995; 47: 1023-1030.
23. Thomsen K. Lithium clearance as a measure of sodium and water delivery from the proximal tubules. Kidney Int 1990; 37 (Suppl 28): S10-S16.
24. Thomsen K, Holstein-Rathlou NH, Leyssac PP. Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time, and micropuncture. Am J Physiol 1981; 241: F348-F355.
25. 2-rebreathing and the direct Fick method. Acta Anaesthesiol Scand 1995; 39: 245-251.
26. Heigenhauser GJF, Hons BA, Jones NL. Measurement of cardiac output by carbon dioxide rebreathing methods. Clin Chest Med 1989; 10: 255-264.
27. 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochlonde. Am J Cardiol 1988; 62: 46C-52C.
28. Olsen NV, Lang-Jensen T, Hansen JM, et al. Effects of acute β-adrenoceptor blockade with metoprolol on the renal response to dopamine in normal humans. Br J Clin Pharmacol 1994; 37: 347-353.
29. Olsen NV, Olsen MH, Fogh-Andersen N, et al. Lithium clearance method and the renal response to low-dose dopamine in man: a randomized, controlled study. Clin Sci 1993; 84: 237-242.
30. Schoors DF, Dupont AG. Further studies on the mechanism of the natriuretic response to low-dose dopamine in man: effect on lithium clearance and nephrogenic cAMP formation. Eur J Clin Invest 1990; 20: 385-391.
31. Jose PA, Eisner GM, Robillard JE. Renal hemodynamics and natriuresis induced by the dopamine-1 agonist, SKF 82526. Am J Med Sci 1987; 294: 181-186.
32. Hegde SS, Ricci A, Amenta F, Lokhandwala MF. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of tenoldopam. J Pharmacol Exp Ther 1989; 251: 1237-1245.
33. Felder CC, McKelvey AM, Gitler MS, Eisner GM, Jose PA. Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int 1989; 36: 183-193.
34. Bruun NE, Skott P, Lønborg-Jensen H, Giese J. Unchanged lithium clearance during acute amiloride treatment in sodium-depleted man. Scand J Clin Lab Invest 1989; 49: 259-263, 1989.
35. Shirley DG, Singer DRJ, Sagnella GA, et al. Effect of a single test dose of lithium carbonate on sodium and potassium excretion in man. Clin Sci 1991; 81: 59-63.
36. 1-dopamine receptor stimulation by fenoldopam in normal man. Br J Clin Pharmacol 1990; 29: 413-415.
37. Ragsdale NV, Lynd M, Chevalier RL, Felder RA, Peach MJ, Carey RM. Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans. Hypertension 1990; 15: 914-921.
38. Weinstein AM. Glomerulotubular balance in a mathematical model of the proximal nephron. Am J Physiol 1990; 258: F612-F626.
39. De Wardener HE. The control of sodium excretion. Am J Physiol 1978; 235: F163-F173.
40. Olsen NV, Hansen JM, Ladefoged SD, Fogh-Andersen N, Levin-Nielsen S, Leyssac PP. Overall renal and tubular function during infusion of amino acids in normal man. Clin Sci 1990; 78: 497-501.
41. 1 dopamine receptors in renal cortical collecting duct. Am J Physiol 1991; 261: F890-F895.
42. Fadem SZ, Hermandez-Llamas G, Patak RV, Rosenblatt SG, Lifschitz MD, Stein JH. Studies on the mechanism of sodium excretion during drug-induced vasodilatation in the dog. J Clin Invest 1982; 69: 604-610.
43. Haas JA, Granger JP, Knox FG. Effect of renal perfusion pressure on sodium reabsorption from proximal tubules of superficial and deep nephrons. Am J Physiol 1986; 250: F425-F429.
44. Olsen ME, Hall JE, Montani JP, Gayton AC, Langford HG, Cornell JE. Mechanism of angiotensin II natriuresis and antinatriuresis. Am J Physiol 1985; 249: F299-F307.
45. Gundert-Remy U, Penzien J, Hildebrandt R, Mäurer W, Weber E. Correlation between the pharmacokinetics and pharmacodynamics of dopamine in healthy subjects. Eur J Clin Pharmacol 1984; 26: 163-169.
46. Järnberg PO, Bengtsson L, Ekstrand J, Hamberger B. Dopamine infusion in man. Plasma catecholamine levels and pharmacokinetics. Acta Anaesth Scand 1981; 25: 328-331.
47. Goodall McC, Alton H. Metabolism of 3-hydroxytyramine (dopamine) in human subjects. Biochem Pharmacol 1968; 17: 905-914.
48. Ratge D, Steegmüller U, Mikus G, Kohse KP, Wisser H. Dopamine infusion in healthy subjects and critically ill patients. Clin Exp Pharmacol Physiol 1990; 17: 361-369.
49. Silverberg AB, Shah SD, Raymond MW, Cryer PE. Norepinephrine: hormone and neurotransmitter in man. Am J Physiol 1978; 234: E252-E256.
50. Hansen JM, Abildgaard U, Fogh-Andersen N, et al. The transplanted human kidney does not achieve functional reinnervation. Clin Sci 1994; 87: 13-20.